Does VEDOLIZUMAB Cause Fluid retention? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Fluid retention have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.3% of all adverse event reports for VEDOLIZUMAB.
223
Reports of Fluid retention with VEDOLIZUMAB
0.3%
of all VEDOLIZUMAB reports
152
Deaths
188
Hospitalizations
How Dangerous Is Fluid retention From VEDOLIZUMAB?
Of the 223 reports, 152 (68.2%) resulted in death, 188 (84.3%) required hospitalization, and 151 (67.7%) were considered life-threatening.
Is Fluid retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Fluid retention?
AMBRISENTAN (3,927)
TREPROSTINIL (3,804)
MACITENTAN (2,861)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (2,233)
SACUBITRIL\VALSARTAN (2,187)
ADALIMUMAB (1,193)
SELEXIPAG (1,044)
FUROSEMIDE (1,020)
LENALIDOMIDE (1,007)
EPOPROSTENOL (929)
Which VEDOLIZUMAB Alternatives Have Lower Fluid retention Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB